Literature DB >> 10321732

JTB: a novel membrane protein gene at 1q21 rearranged in a jumping translocation.

S Hatakeyama1, M Osawa, M Omine, F Ishikawa.   

Abstract

1q21 is frequently involved in different types of translocation in many types of cancers. Jumping translocation (JT) is an unbalanced translocation that comprises amplified chromosomal segments jumping to various telomeres. In this study, we identified a novel gene human JTB (Jumping Translocation Breakpoint) at 1q21, which fused with the telomeric repeats of acceptor telomeres in a case of JT. hJTB (human JTB) encodes a trans-membrane protein that is highly conserved among divergent eukaryotic species. JT results in a hJTB truncation, which potentially produces an hJTB product devoid of the trans-membrane domain. hJTB is located in a gene-rich region at 1q21, called EDC (Epidermal Differentiation Complex). This is the first report identifying the gene involved in unbalanced translocations at 1q21.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10321732     DOI: 10.1038/sj.onc.1202510

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  11 in total

1.  Target highlights in CASP9: Experimental target structures for the critical assessment of techniques for protein structure prediction.

Authors:  Andriy Kryshtafovych; John Moult; Sergio G Bartual; J Fernando Bazan; Helen Berman; Darren E Casteel; Evangelos Christodoulou; John K Everett; Jens Hausmann; Tatjana Heidebrecht; Tanya Hills; Raymond Hui; John F Hunt; Jayaraman Seetharaman; Andrzej Joachimiak; Michael A Kennedy; Choel Kim; Andreas Lingel; Karolina Michalska; Gaetano T Montelione; José M Otero; Anastassis Perrakis; Juan C Pizarro; Mark J van Raaij; Theresa A Ramelot; Francois Rousseau; Liang Tong; Amy K Wernimont; Jasmine Young; Torsten Schwede
Journal:  Proteins       Date:  2011-10-21

2.  The IgG Fc receptor, FcgammaRIIB, is a target for deregulation by chromosomal translocation in malignant lymphoma.

Authors:  M B Callanan; P Le Baccon; P Mossuz; S Duley; C Bastard; R Hamoudi; M J Dyer; G Klobeck; R Rimokh; J J Sotto; D Leroux
Journal:  Proc Natl Acad Sci U S A       Date:  2000-01-04       Impact factor: 11.205

3.  Jumping Translocations in Myeloid Malignancies Associated With Treatment Resistance and Poor Survival.

Authors:  David Sanford; Courtney D DiNardo; Guilin Tang; Jorge E Cortes; Srdan Verstovsek; Elias Jabbour; Farhad Ravandi; Hagop Kantarjian; Guillermo Garcia-Manero
Journal:  Clin Lymphoma Myeloma Leuk       Date:  2015-06-06

4.  Frequent gain of chromosome band 1q21 in plasma-cell dyscrasias detected by fluorescence in situ hybridization: incidence increases from MGUS to relapsed myeloma and is related to prognosis and disease progression following tandem stem-cell transplantation.

Authors:  Ichiro Hanamura; James P Stewart; Yongsheng Huang; Fenghuang Zhan; Madhumita Santra; Jeffrey R Sawyer; Klaus Hollmig; Maurizio Zangarri; Mauricio Pineda-Roman; Frits van Rhee; Federica Cavallo; Bart Burington; John Crowley; Guido Tricot; Bart Barlogie; John D Shaughnessy
Journal:  Blood       Date:  2006-05-16       Impact factor: 22.113

5.  Studies on the molecular pathogenesis of extraskeletal myxoid chondrosarcoma-cytogenetic, molecular genetic, and cDNA microarray analyses.

Authors:  Helene Sjögren; Jeanne M Meis-Kindblom; Charlotte Orndal; Peter Bergh; Konrad Ptaszynski; Pierre Aman; Lars-Gunnar Kindblom; Göran Stenman
Journal:  Am J Pathol       Date:  2003-03       Impact factor: 4.307

6.  Jumping translocations in myelodysplastic syndromes.

Authors:  Cecilia C S Yeung; H Joachim Deeg; Colin Pritchard; David Wu; Min Fang
Journal:  Cancer Genet       Date:  2016-08-08

7.  Genomic organization, alternative splicing and tissues expression of porcine CREB3L4 gene.

Authors:  Y M Qi; T Lei; L Zhou; X D Chen; Q Q Long; H Long; D Jin; L Gan; Z Q Yang
Journal:  Mol Biol Rep       Date:  2008-11-04       Impact factor: 2.316

8.  Evidence for a novel mechanism for gene amplification in multiple myeloma: 1q12 pericentromeric heterochromatin mediates breakage-fusion-bridge cycles of a 1q12 approximately 23 amplicon.

Authors:  Jeffrey R Sawyer; Erming Tian; Edward Thomas; Mark Koller; Colin Stangeby; Gael Sammartino; Linda Goosen; Charles Swanson; Regina L Binz; Bart Barlogie; John Shaughnessy
Journal:  Br J Haematol       Date:  2009-09-09       Impact factor: 6.998

9.  Overexpression of PDZK1 within the 1q12-q22 amplicon is likely to be associated with drug-resistance phenotype in multiple myeloma.

Authors:  Jun Inoue; Takemi Otsuki; Akira Hirasawa; Issei Imoto; Yoshinobu Matsuo; Shiroh Shimizu; Masafumi Taniwaki; Johji Inazawa
Journal:  Am J Pathol       Date:  2004-07       Impact factor: 4.307

10.  HBsAg inhibits the translocation of JTB into mitochondria in HepG2 cells and potentially plays a role in HCC progression.

Authors:  Yun-Peng Liu; Xiao-Ning Yang; Amarsanaa Jazag; Jin-Shui Pan; Tian-Hui Hu; Jing-Jing Liu; Bayasi Guleng; Jian-Lin Ren
Journal:  PLoS One       Date:  2012-05-15       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.